VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $43,158,852.08

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$471.91

▲ +1.86 (0.40%)

As of 10/24/2024 01:00 AM ET

Days: 30 | 90 | 365

The real reason Elon is fully endorsing Trump

From Porter & Company | Ad

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/24/2024	Orrstown Financial Services Inc.	699	$0.33M	0.1%	+15.7%	0.000%
10/24/2024	Nisa Investment Advisors LLC	75,350	$35.04M	0.2%	+3.0%	0.029%
10/24/2024	Patriot Financial Group Insurance Agency LLC	3,384	$1.57M	0.2%	+9.8%	0.001%
10/24/2024	Concord Wealth Partners	2,646	$1.23M	0.2%	+15.2%	0.001%
10/24/2024	Vivid Wealth Management LLC	4,352	$2.02M	1.1%	N/A	0.002%
10/24/2024	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	1,926	$0.90M	0.1%	+4.7%	0.001%
10/24/2024	Tower View Wealth Management LLC	4,887	$2.27M	1.2%	+1.7%	0.002%
10/24/2024	Baker Tilly Wealth Management LLC	2,289	$1.07M	0.5%	+21.2%	0.001%
10/24/2024	Cavalier Investments LLC	7,297	$3.39M	1.0%	+6.0%	0.003%
10/24/2024	Custom Index Systems LLC	1,234	$0.57M	0.3%	-9.1%	0.000%
10/24/2024	J.W. Cole Advisors Inc.	689	$0.32M	0.0%	-18.5%	0.000%
10/24/2024	State of Alaska Department of Revenue	47,975	$22.31M	0.2%	-4.7%	0.019%
10/24/2024	Valley National Advisers Inc.	122	$56K	0.0%	-24.2%	0.000%
10/24/2024	Mcrae Capital Management Inc.	31,880	$14.83M	2.9%	-4.9%	0.012%
10/24/2024	Mattern Capital Management LLC	1,729	$0.80M	0.1%	+8.9%	0.001%
10/24/2024	DekaBank Deutsche Girozentrale	506,457	$233.37M	0.4%	+1.0%	0.196%
10/24/2024	Modera Wealth Management LLC	24,993	$11.62M	0.1%	+0.7%	0.010%
10/24/2024	GHP Investment Advisors Inc.	102	$47K	0.0%	+64.5%	0.000%
10/24/2024	Boston Trust Walden Corp	960	$0.45M	0.0%	-13.5%	0.000%
10/24/2024	PFG Investments LLC	1,773	$0.83M	0.1%	+1.8%	0.001%
10/24/2024	Arkadios Wealth Advisors	671	$0.31M	0.0%	N/A	0.000%
10/24/2024	NorthCrest Asset Manangement LLC	1,418	$0.66M	0.0%	+15.3%	0.001%
10/24/2024	Forsta AP Fonden	59,900	$27.86M	0.2%	+11.1%	0.023%
10/23/2024	Groesbeck Investment Management Corp NJ	1,769	$0.82M	1.1%	-1.4%	0.001%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	102,285	$47.35M	0.2%	+10.9%	0.040%
10/23/2024	Louisiana State Employees Retirement System	34,200	$15.91M	0.3%	-2.6%	0.013%
10/23/2024	Outlook Wealth Advisors LLC	892	$0.42M	0.1%	+2.8%	0.000%
10/23/2024	Allworth Financial LP	1,649	$0.77M	0.0%	-6.5%	0.001%
10/23/2024	Highland Capital Management LLC	6,236	$2.90M	0.2%	-3.7%	0.002%
10/23/2024	Cromwell Holdings LLC	830	$0.39M	0.2%	+4.5%	0.000%
10/23/2024	Sigma Investment Counselors Inc.	8,937	$4.16M	0.2%	+3.0%	0.003%
10/23/2024	Mediolanum International Funds Ltd	5,299	$2.45M	0.0%	-85.8%	0.002%
10/23/2024	Lake Street Advisors Group LLC	2,616	$1.22M	0.1%	-50.6%	0.001%
10/23/2024	Cullinan Associates Inc.	54,662	$26.25M	1.4%	-1.8%	0.021%
10/23/2024	HWG Holdings LP	2,278	$1.06M	0.4%	+25,211.1%	0.001%
10/23/2024	Ballentine Partners LLC	5,471	$2.54M	0.0%	+2.3%	0.002%
10/23/2024	Moody Lynn & Lieberson LLC	65,207	$30.33M	1.9%	+15.6%	0.025%
10/23/2024	E. Ohman J or Asset Management AB	10,310	$4.80M	0.1%	-6.8%	0.004%
10/23/2024	Schmidt P J Investment Management Inc.	2,021	$0.94M	0.2%	+10.0%	0.001%
10/23/2024	Dakota Wealth Management	34,393	$16M	0.4%	+13.3%	0.013%
10/23/2024	Global Trust Asset Management LLC	1,037	$0.48M	0.2%	+26.9%	0.000%
10/23/2024	Assenagon Asset Management S.A.	311,643	$144.94M	0.3%	+224.0%	0.121%
10/23/2024	IFM Investors Pty Ltd	53,422	$24.85M	0.2%	-0.1%	0.021%
10/23/2024	Bogart Wealth LLC	19,228	$8.94M	0.4%	+1.2%	0.007%
10/23/2024	Jackson Wealth Management LLC	3,548	$1.65M	0.2%	+90.1%	0.001%
10/23/2024	Commonwealth Financial Services LLC	437	$0.21M	0.0%	N/A	0.000%
10/23/2024	Greystone Financial Group LLC	1,117	$0.52M	0.1%	+24.8%	0.000%
10/23/2024	CENTRAL TRUST Co	9,987	$4.65M	0.1%	-0.8%	0.004%
10/23/2024	Global Assets Advisory LLC	901	$0.42M	0.2%	N/A	0.000%
10/23/2024	First National Bank of Hutchinson	2,086	$0.97M	0.6%	-11.6%	0.001%
10/23/2024	Brighton Jones LLC	3,848	$1.79M	0.1%	-10.5%	0.001%
10/22/2024	International Assets Investment Management LLC	324,626	$150.98M	0.0%	+74,015.5%	0.126%
10/22/2024	McAdam LLC	2,636	$1.23M	0.1%	+4.6%	0.001%
10/22/2024	Lake Street Private Wealth LLC	5,185	$2.41M	0.4%	+212.9%	0.002%
10/22/2024	Guidance Capital Inc.	1,706	$0.82M	0.3%	+9.6%	0.001%
10/22/2024	Hartford Investment Management Co.	16,250	$7.56M	0.2%	-1.7%	0.006%
10/22/2024	Commerzbank Aktiengesellschaft FI	1,272	$0.59M	0.0%	+48.3%	0.000%
10/22/2024	GAM Holding AG	10,291	$4.79M	0.4%	+15.5%	0.004%
10/22/2024	Private Advisor Group LLC	7,244	$3.37M	0.0%	-11.9%	0.003%
10/22/2024	Segment Wealth Management LLC	5,715	$2.66M	0.2%	+26.9%	0.002%
10/22/2024	BLB&B Advisors LLC	527	$0.25M	0.0%	+23.4%	0.000%
10/22/2024	Stanley Laman Group Ltd.	436	$0.20M	0.0%	N/A	0.000%
10/22/2024	Symphony Financial Ltd. Co.	1,390	$0.64M	0.1%	-36.8%	0.001%
10/22/2024	Waldron Private Wealth LLC	5,083	$2.36M	0.1%	+1.6%	0.002%
10/22/2024	Pegasus Asset Management Inc.	5,670	$2.64M	1.0%	-1.1%	0.002%
10/22/2024	Eastern Bank	1,731	$0.81M	0.0%	N/A	0.001%
10/22/2024	My Legacy Advisors LLC	2,227	$1.04M	0.4%	-14.5%	0.001%
10/22/2024	Signaturefd LLC	5,149	$2.40M	0.0%	+1.1%	0.002%
10/22/2024	Sequoia Financial Advisors LLC	12,288	$5.72M	0.1%	+10.3%	0.005%
10/21/2024	Kessler Investment Group LLC	13,770	$6.40M	3.3%	-1.9%	0.005%
10/21/2024	Oakworth Capital Inc.	167	$78K	0.0%	+17.6%	0.000%
10/21/2024	Foundations Investment Advisors LLC	849	$0.40M	0.0%	+11.3%	0.000%
10/21/2024	Whittier Trust Co. of Nevada Inc.	576	$0.27M	0.0%	+4.5%	0.000%
10/21/2024	Whittier Trust Co.	1,533	$0.71M	0.0%	+5.9%	0.001%
10/21/2024	Western Financial Corp CA	879	$0.41M	0.2%	N/A	0.000%
10/21/2024	Northwest Investment Counselors LLC	54	$25K	0.0%	N/A	0.000%
10/21/2024	Retirement Guys Formula LLC	2,901	$1.35M	0.6%	+3.2%	0.001%
10/21/2024	Little House Capital LLC	3,723	$1.73M	0.5%	+38.4%	0.001%
10/21/2024	Cassia Capital Partners LLC	1,637	$0.76M	0.5%	-7.4%	0.001%
10/21/2024	1858 Wealth Management LLC	2,619	$1.22M	1.0%	-1.6%	0.001%
10/21/2024	Toth Financial Advisory Corp	1,550	$0.72M	0.1%	+1,450.0%	0.001%
10/21/2024	Trilogy Capital Inc.	3,617	$1.68M	0.1%	+26.1%	0.001%
10/21/2024	Koss Olinger Consulting LLC	896	$0.42M	0.0%	+4.1%	0.000%
10/19/2024	Allspring Global Investments Holdings LLC	236,326	$109.91M	0.2%	+18.8%	0.092%
10/19/2024	Cyndeo Wealth Partners LLC	1,291	$0.60M	0.0%	N/A	0.001%
10/19/2024	Cedrus LLC	774	$0.36M	0.1%	+18.3%	0.000%
10/19/2024	New Century Financial Group LLC	889	$0.41M	0.2%	-25.1%	0.000%
10/18/2024	Resonant Capital Advisors LLC	1,226	$0.57M	0.0%	+13.4%	0.000%
10/18/2024	Veracity Capital LLC	1,618	$0.75M	0.3%	+16.7%	0.001%
10/18/2024	Whitaker Myers Wealth Managers LTD.	802	$0.37M	0.1%	N/A	0.000%
10/18/2024	Chicago Capital LLC	12,292	$5.72M	0.2%	-3.0%	0.005%
10/18/2024	Harfst & Associates Inc.	476	$0.22M	0.0%	-53.4%	0.000%
10/18/2024	Raymond James & Associates	325,391	$151.33M	0.1%	+4.7%	0.126%
10/18/2024	Slow Capital Inc.	12,639	$5.88M	0.9%	-0.2%	0.005%
10/18/2024	First Citizens Bank & Trust Co.	25,989	$12.09M	0.2%	-5.1%	0.010%
10/18/2024	Capital Investment Advisors LLC	872	$0.41M	0.0%	+4.4%	0.000%
10/18/2024	Blue Trust Inc.	2,711	$1.27M	0.0%	+87.9%	0.001%
10/18/2024	Riverview Trust Co	254	$0.12M	0.1%	+30.9%	0.000%
10/18/2024	Moss Adams Wealth Advisors LLC	563	$0.26M	0.0%	+7.6%	0.000%
10/18/2024	Net Worth Advisory Group	1,479	$0.69M	0.2%	N/A	0.001%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $471.91

$471.90

$477.84

50 Day Range

MA: $475.60

$448.60

$498.73

52 Week Range

Now: $471.91

$341.90

$510.64

Volume

674,014 shs

Average Volume

1,171,897 shs

Market Capitalization

$121.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Lloyd Carney (Director)
Yuchun Lee (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Swedbank AB — 0.22%
DekaBank Deutsche Girozentrale — 0.20%
Handelsbanken Fonder AB — 0.16%
Raymond James & Associates — 0.13%
International Assets Investment Management LLC — 0.13%
Assenagon Asset Management S.A. — 0.12%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
AMF Tjanstepension AB
Swedbank AB
Vontobel Holding Ltd.
Mediolanum International Funds Ltd
Simplicity Wealth LLC
Bleakley Financial Group LLC
Foster Victor Wealth Advisors LLC
Handelsbanken Fonder AB
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
International Assets Investment Management LLC
Assenagon Asset Management S.A.
Allspring Global Investments Holdings LLC
Raymond James & Associates
Boston Common Asset Management LLC
Mirae Asset Global Investments Co. Ltd.
Teamwork Financial Advisors LLC
Connective Portfolio Management LLC